Regina Miracle's half-year profit dropped over 30% year-on-year, how is the revenue performance?
On November 27, the Financial Association brings you today's important announcements from the Hong Kong stock market.
1) Company News
Regina Miracle (02199.HK): Released mid-term results, revenue of approximately 3.978 billion Hong Kong dollars, a year-on-year increase of 12.2%, mainly due to increased demand from brand partners as the global market conditions overall warm up and the consumer brand destocking cycle approaches its end; net income of 67.619 million Hong Kong dollars, a year-on-year decrease of 36.7%.
Yuanheng Gas (00332.HK): Released mid-term results, revenue of 0.533 billion yuan, a year-on-year decrease of 83.29%, net loss of 0.116 billion yuan, a year-on-year shift from profit to loss.
HK Finance GP (01273.HK): Released mid-term results, interest income of 82.959 million Hong Kong dollars, a year-on-year increase of 13.4%; net profit of 24.359 million Hong Kong dollars, a year-on-year increase of 17.63%;
Rykadan Capital (02288.HK): Released mid-term results, revenue of 73.821 million Hong Kong dollars, a year-on-year increase of 12.59 times; loss of 88.757 million Hong Kong dollars, a year-on-year increase of 51.44%.
Chengdu Expway (01785.HK): Chengwenqiong Expressway Company signed a land acquisition and demolition agreement for the Wenjiang District with the Wenjiang District government.
Sino Biopharm (01177.HK): Bemarituzumab injection combined with Anlotinib hydrochloride capsules has been approved for the treatment of endometrial cancer.
CMS (00867.HK): The innovative drug GLP-1R/GCGR dual agonist CMS-D005 has received the drug clinical trial approval notice.
Noiz Group (08163.HK): Completed the issuance of convertible securities with a principal amount of 0.101 billion HKD.
2) Repurchase Dynamics
AIA (01299.HK): Invested 0.447 billion HKD to repurchase shares amounting to 7.761 million shares, with a repurchase price of 56.9-58.25 HKD per share.
Tencent (00700.HK): Invested 0.704 billion HKD to repurchase 1.77 million shares, with a repurchase price of 393.2-405.8 HKD per share.
Sinopec Corp (00386.HK): Invested 25.7472 million HKD to repurchase 6.204 million shares, with a repurchase price of 4.13-4.2 HKD per share.
HSBC Holdings (00005) announced that on November 26, 2024, the company invested 0.175 billion HKD to repurchase 2.456 million shares, with a repurchase price of 71.3-71.6 HKD.